The Polynovo Ltd (ASX: PNV) share price is up 1.9% in late afternoon trading to $2.13 per share.
The S&P/ASX 200 Index (ASX: XJO), meanwhile, is struggling to hold on to its earlier gains, though currently still up 0.2%.
Polynovo is under the microscope today as the ASX medical device developer gets set to deliver its full year 2021 financial results (FY21) tomorrow.
With investors keenly awaiting Thursday’s results, we look back to how the Polynovo share price moved following the release of its FY20 results.
What did Polynovo report in FY20?
The Polynovo share price fell 6.5% on 26 August 2020, the day the company reported its FY20 results.
The fall came despite a 104% increase in sales revenue reported over the year, to $19.1 million. Revenue grew across the company’s markets, with particularly strong growth in the United States.
Likely contributing to Polynovo shares falling after last year’s results was the 28.8% year-on-year increase in operating expenses which reached $22.6 million. The company reported an operating loss of $1.1 million and a net loss after tax of $4.2 million.
Polynovo finished off FY20 with a cash balance of $11.6 million.
No guidance was offered for FY21. However, management said at the time they planned to reinvest funds back into the business for new product development and to expand into new markets.
Polynovo share price snapshot
Over the past 12 months, Polynovo’s share price is down 10%. By comparison the ASX 200 is up 22% since this time last year.
Year-to-date, the Polynovo has yet to recover from the sharp falls it suffered in January. Its shares are down 45% in 2021.
The post How did the Polynovo (ASX:PNV) share price respond last earnings season? appeared first on The Motley Fool Australia.
Should you invest $1,000 in Polynovo right now?
Before you consider Polynovo, you’ll want to hear this.
Motley Fool Investing expert Scott Phillips just revealed what he believes are the 5 best stocks for investors to buy right now… and Polynovo wasn’t one of them.
The online investing service he’s run for nearly a decade, Motley Fool Share Advisor, has provided thousands of paying members with stock picks that have doubled, tripled or even more.* And right now, Scott thinks there are 5 stocks that are better buys.
*Returns as of August 16th 2021
More reading
- These are the 10 most shorted ASX shares
- The Polynovo (ASX:PNV) share price is up 7% this month. Here’s why
- These are the 10 most shorted ASX shares
- The best and worst performing ASX 200 healthcare shares of 2021
- These are the 10 most shorted ASX shares
The Motley Fool Australia’s parent company Motley Fool Holdings Inc. owns shares of and has recommended POLYNOVO FPO. The Motley Fool Australia has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.
from The Motley Fool Australia https://ift.tt/3grRM1x
Leave a Reply